Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.
Genetic and Structural Variation in the O-Antigen of Salmonella enterica Serovar Typhimurium Isolates Causing Bloodstream Infections in the Democratic Republic of the Congo.
Journal article
Van Puyvelde S. et al, (2022), mBio
Pivotal Shigella Vaccine Efficacy Trials-Study Design Considerations from a Shigella Vaccine Trial Design Working Group.
Journal article
Pavlinac PB. et al, (2022), Vaccines, 10
The Background, Role and Approach for Development of a Controlled Human Infection Model for Nontyphoidal Salmonella.
Journal article
MacLennan CA., (2021), Current topics in microbiology and immunology
An adsorption method to prepare specific antibody-depleted normal human serum as a source of complement for human serum bactericidal assays for Salmonella.
Journal article
Siggins MK. and MacLennan CA., (2021), Vaccine
Typhoid in India: An Age-old Problem With an Existing Solution.
Journal article
Kumar S. et al, (2021), The Journal of infectious diseases, 224, S469 - S474
Critical needs in advancing Shigella vaccines for global health
Journal article
MacLennan CA. et al, (2021), The Journal of Infectious Diseases
The immunology of infection
Journal article
Gilchrist JJ. and MacLennan CA., (2021), Medicine (United Kingdom)
Outer membrane protein size and LPS O-antigen define protective antibody targeting to the Salmonella surface
Journal article
Domínguez-Medina CC. et al, (2020), Nature Communications, 11
Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM197 conjugate vaccine.
Journal article
Micoli F. et al, (2020), Proceedings of the National Academy of Sciences of the United States of America, 117, 24443 - 24449
Outer membrane vesicle vaccines
Journal article
Micoli F. and MacLennan CA., (2020), Seminars in Immunology, 50, 101433 - 101433
Typhoid Conjugate Vaccines and Enteric Fever Control: Where to Next?
Journal article
Steele AD. et al, (2020), Clinical Infectious Diseases, 71, S185 - S190
Gonococcal vaccines: Public health value and preferred product characteristics; report of a WHO global stakeholder consultation, January 2019
Journal article
Gottlieb SL. et al, (2020), Vaccine, 38, 4362 - 4373
Consensus Report on Shigella Controlled Human Infection Model: Clinical Endpoints
Journal article
MacLennan CA. et al, (2019), Clinical Infectious Diseases, 69, S591 - S595
Consensus Report on Shigella Controlled Human Infection Model: Introduction and Overview
Journal article
MacLennan CA. et al, (2019), Clinical Infectious Diseases, 69, S577 - S579
Consensus Report on Shigella Controlled Human Infection Model: Immunological Assays.
Journal article
Kaminski RW. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S596 - S601
Consensus Report on Shigella Controlled Human Infection Model: Conduct of Studies.
Journal article
Talaat KR. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S580 - S590
The Severe Typhoid Fever in Africa Program: Study Design and Methodology to Assess Disease Severity, Host Immunity, and Carriage Associated With Invasive Salmonellosis.
Journal article
Park SE. et al, (2019), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 69, S422 - S434
Genomic characterization of novel Neisseria species.
Journal article
Diallo K. et al, (2019), Scientific reports, 9
How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella?
Journal article
Giersing BK. et al, (2019), Vaccine, 37, 4778 - 4783
Cross-sectional study of IgG antibody levels to invasive nontyphoidal Salmonella LPS O-antigen with age in Uganda
Journal article
Stockdale L. et al, (2019), Gates Open Research, 3, 1501 - 1501